Author details

Full Name

Paloma Valverde

Affiliation

ORCID

Career Start Year

1992

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35113037	Puberty and sex in pediatric thyroid cancer: could expression of estrogen and progesterone receptors affect prognosis?	European Thyroid Journal	2022
35887149	Body Hypomethylation Is Frequent in Tumors from the Digestive and Respiratory Tracts and Is Associated with Risk-Factor Exposure.	International Journal of Molecular Sciences	2022
32986862	Identification and characterization of a novel adiponectin receptor agonist adipo anti-inflammation agonist and its anti-inflammatory effects in vitro and in vivo.	Br J Pharmacol	2021
34273868	Osteogenic effects of microRNA-335-5p/lipidoid nanoparticles coated on titanium surface.	Arch Oral Biol	2021
31541471	Potential roles of miR-335-5p on pathogenesis of experimental periodontitis.	J Periodontal Res	2020
32085563	Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma.	Cancers	2020
30626266	An Adiponectin Receptor Agonist Reduces Type 2 Diabetic Periodontitis.	J Dent Res	2019
30479003	Central adiponectin induces trabecular bone mass partly through epigenetic downregulation of cannabinoid receptor CB1.	J Cell Physiol	2019
29886386	A novel Lipidoid-MicroRNA formulation promotes calvarial bone regeneration.	Biomaterials	2018
28846804	Overexpression of MiR-335-5p Promotes Bone Formation and Regeneration in Mice.	J Bone Miner Res	2017
28944087	Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism.	Bone Res	2017
26399931	Epigenetic Modulation in Periodontitis: Interaction of Adiponectin and JMJD3-IRF4 Axis in Macrophages.	J Cell Physiol	2016
26899552	Recurrent acute thermal lesion induces esophageal hyperproliferative premalignant lesions in mice esophagus.	Experimental and Molecular Pathology	2016
25187480	Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: an approach for treating bone disease in diabetes.	Stem Cells	2015
26258051	Study of a two species microbial community by an inferential comparative genomic analysis tool: Spatial Analytical Microbial Imaging.	MethodsX	2015
24780611	Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice.	Am J Physiol Endocrinol Metab	2014
24836538	Adiponectin ameliorates experimental periodontitis in diet-induced obesity mice.	PLoS One	2014
18597627	Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice.	J Bone Miner Res	2008
18096892	Phenotypic analysis of Dlx5 overexpression in post-natal bone.	J Dent Res	2008
18288984	Pharmacotherapies to manage bone loss-associated diseases: a quest for the perfect benefit-to-risk ratio.	Current Medicinal Chemistry	2008
17630878	Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone.	Tissue Eng	2007
16936272	B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.	American Journal of Pathology	2006
16095557	Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.	Archives of Oral Biology	2006
16466699	Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells.	Biochem Biophys Res Commun	2006
16277573	Immune response: the key to bone resorption in periodontal disease.	Journal of Periodontology	2005
29539039	Immune Response: The Key to Bone Resorption in Periodontal Disease.	Journal of Periodontology	2005
16099947	Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases.	FASEB Journal	2005
15914584	Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease.	Journal of Dental Research	2005
15958209	Effects of Gas6 and hydrogen peroxide in Axl ubiquitination and downregulation.	Biochemical and Biophysical Research Communications	2005
16059638	BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.	J Bone Miner Res	2005
14753747	Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.	Journal of Bone and Mineral Research	2004
14729352	Regulation of the ubiquitin proteasome pathway in human lens epithelial cells during the cell cycle.	Experimental Eye Research	2004
14667825	Role of Gas6/Axl signaling in lens epithelial cell proliferation and survival.	Experimental Eye Research	2004
11027580	Cloning, expression, and mapping of hWW45, a novel human WW domain-containing gene.	Biochemical and Biophysical Research Communications	2000
10222341	Purification and preliminary characterization of a cardiac Kv1.5 repressor element binding factor.	Circulation Research	1999
8857670	Activation of tyrosinase reduces the cytotoxic effects of the superoxide anion in B16 mouse melanoma cells.		1996
8981022	Tyrosinase may protect human melanocytes from the cytotoxic effects of the superoxide anion.	Experimental Dermatology	1996
8894704	The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma.	Human Molecular Genetics	1996
7556159	Melatonin antagonizes alpha-melanocyte-stimulating hormone enhancement of melanogenesis in mouse melanoma cells by blocking the hormone-induced accumulation of the c locus tyrosinase.		1995
7581459	Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans.	Nature Genetics	1995
7901010	Tyrosinase isoenzymes in mammalian melanocytes. 2. Differential activation by alpha-melanocyte-stimulating hormone.		1993
7511805	Improved tyrosinase activity stains in polyacrylamide electrophoresis gels.		1993
8223598	Tyrosinase isoenzymes in mammalian melanocytes. 1. Biochemical characterization of two melanosomal tyrosinases from B16 mouse melanoma.		1993
8234201	Preparation of purified tyrosinase devoid of dopachrome tautomerase from mammalian malignant melanocytes.		1993
1352258	Melanocyte stimulating hormone activation of tyrosinase in B16 mouse melanoma cells. Evidence for a differential induction of two distinct isoenzymes.	FEBS Letters	1992
1497341	Proteolysis with trypsin of mammalian tyrosinase isoforms from B16 mouse melanoma.	Archives of Biochemistry and Biophysics	1992